Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 16.31%-374.21K | 43.39%-81.32K | -57.91%-129.56K | 2.32%-105.28K | 48.92%-58.05K | 46.18%-447.14K | -27.06%-143.66K | 63.66%-82.05K | 41.53%-107.77K | 63.05%-113.66K |
| Net income from continuing operations | -476.25%-2.17M | -408.59%-723.41K | -1,175.15%-1.02M | -3,174.37%-139.39K | -95.88%-296.17K | -899.32%-377.31K | -6.33%-142.24K | -206.54%-79.62K | 96.72%-4.26K | -164.07%-151.2K |
| Operating gains losses | 3,314.95%1.79M | 2,279.19%659.46K | 66,550.87%876.46K | 132.61%41.96K | 391.77%215.74K | 93.88%-55.79K | 114.22%27.72K | 100.63%1.32K | -28.93%-128.69K | 110.76%43.87K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Change In working capital | 145.63%6.41K | 40.35%-17.38K | 347.02%9.25K | -131.18%-7.85K | 453.55%22.38K | 94.47%-14.04K | -136.08%-29.14K | 96.33%-3.75K | 6.87%25.18K | 96.11%-6.33K |
| -Change in prepaid assets | 1,163.24%23.47K | 131.59%7.87K | -165.00%-4.54K | 7.44%7.9K | -1.53%12.24K | 127.86%1.86K | -27.47%-24.91K | -57.52%6.98K | 939.84%7.36K | 561.76%12.43K |
| -Change in payables and accrued expense | -7.36%-17.07K | -496.88%-25.25K | 228.54%13.79K | -188.42%-15.75K | 154.10%10.15K | 93.56%-15.9K | -158.77%-4.23K | 90.96%-10.73K | -27.07%17.82K | 88.27%-18.76K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 16.31%-374.21K | 43.69%-80.89K | -58.43%-129.99K | 2.32%-105.28K | 48.92%-58.05K | 46.18%-447.14K | -27.06%-143.66K | 63.66%-82.05K | 41.53%-107.77K | 63.05%-113.66K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 11.04K | ||||||||
| Net investment purchase and sale | --0 | ---- | ---- | ---- | ---- | --11.04K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | ---- | ---- | --11.04K | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 189.74K | 0 | ||||||||
| Proceeds from stock option exercised by employees | --189.74K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --189.74K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -42.67%585.86K | -59.28%292.53K | -47.22%422.53K | -41.89%527.8K | -42.67%585.86K | -44.84%1.02M | -36.70%718.47K | -41.17%800.52K | -41.22%908.3K | -44.84%1.02M |
| Current changes in cash | 57.70%-184.48K | 182.07%108.85K | -58.43%-129.99K | 2.32%-105.28K | 48.92%-58.05K | 47.51%-436.1K | -17.30%-132.62K | 63.66%-82.05K | 41.53%-107.77K | 63.05%-113.66K |
| End cash Position | -31.49%401.38K | -31.49%401.38K | -59.28%292.53K | -47.22%422.53K | -41.89%527.8K | -42.67%585.86K | -42.67%585.86K | -36.70%718.47K | -41.17%800.52K | -41.22%908.3K |
| Free cash from | 16.31%-374.21K | 43.69%-80.89K | -58.43%-129.99K | 2.32%-105.28K | 48.92%-58.05K | 46.18%-447.14K | -27.06%-143.66K | 63.66%-82.05K | 41.53%-107.77K | 63.05%-113.66K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.